Anti-CPT1A antibody [EPR21843-71-2F]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(2 Reviews)
|
(64 Publications)
Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) is a rabbit monoclonal antibody detecting CPT1A in Western Blot, Flow Cytometry (Intra), IHC-P. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
View Alternative Names
CPT1, CPT1A, CPT1-L, Carnitine palmitoyltransferase 1A, Succinyltransferase CPT1A, CPT I, CPTI-L
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Flow cytometry overlay histogram showing left wild-type HAP1 positive cells and right negative CPT1A knockout HAP1 stained with ab234111 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab234111) (1x 106 in 100μl at 1 μg/ml (1/481)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C.
Isotype control antibody was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (black line) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-permeabilized SK-OV-3 (human ovarian cancer cell line) cell line labeling CPT1A with ab234111 at 1/50 dilution (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Immunohistochemical analysis of paraffin-embedded human ovarian carcinoma tissue labeling CPT1A with ab234111 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Granular cytoplasmic staining in human ovarian carcinoma (PMID : 26716645) is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Immunohistochemical analysis of paraffin-embedded human kidney tissue labeling CPT1A with ab234111 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Granular cytoplasmic staining in human kidney (PMID : 18192268; PMID : 28956034; PMID : 15363638; PMID : 8679700) is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Immunohistochemical analysis of paraffin-embedded human heart tissue labeling CPT1A with ab234111 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Cytoplasmic staining on human heart is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Immunohistochemical analysis of paraffin-embedded rat kidney tissue labeling CPT1A with ab234111 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Granular cytoplasmic staining in rat kidney (PMID : 18192268; PMID : 28956034; PMID : 15363638; PMID : 8679700) is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue labeling CPT1A with ab234111 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Cytoplasmic staining in mouse kidney (PMID : 18192268; PMID : 28956034; PMID : 15363638; PMID : 8679700) is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Lanes 1- 2 : Merged signal (red and green). Green - ab234111 observed at 88 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab234111 was shown to react with CPT1A in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266319 (knockout cell lysate ab256880) was used. Wild-type HEK-293T and CPT1A knockout HEK-293T cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab234111 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
CPT1A knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human CPT1A knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-cpt1a-knockout-hek-293t-cell-line-ab266319'>ab266319</a>)
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
- WB
Supplier Data
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Blocking and diluting buffer : 5% NFDM /TBST
Lanes 1 - 2:
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) at 1/1000 dilution
Lanes 1 - 2:
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/cpt1a-antibody-epr21843-71-2f-bsa-and-azide-free-ab235841'>ab235841</a>) at 1/1000 dilution
Lane 1:
Human kidney tissue lysate at 20 µg
Lane 2:
Human liver tissue lysate at 1/20 dilution
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Observed band size: 88 kDa
false
Exposure time: 92s
- WB
Supplier Data
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Blocking/Dilution buffer : 5% NFDM/TBST.
ab234111 was shown to specifically react with CPT1A in wild-type HAP1 cells as signal was lost in CPT1A knockout cells. Wild-type and CPT1A knockout samples were subjected to SDS-PAGE. ab234111 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.
All lanes:
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
CPT1A knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 4:
SK-OV-3 (human ovarian cancer cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
Exposure time: 92s
- WB
Supplier Data
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Blocking and diluting buffer : 5% NFDM/TBST
Lanes 1 - 3:
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/cpt1a-antibody-epr21843-71-2f-bsa-and-azide-free-ab235841'>ab235841</a>) at 1/1000 dilution
Lanes 1 - 3:
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) at 1/1000 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma epithelial cell) cell lysate at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) cell lysate at 20 µg
Lane 3:
HepG2 (Human hepatocellular carcinoma epithelial cell) cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 88 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (AB234111)
Exposure time : Lanes 1 and 2 : 3 minutes; Lane 3 : 37 seconds; Lane 4 : 114 seconds; Lane 5 : 15 seconds; Lanes 6 and 7 : 92 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) at 1/1000 dilution
Lane 1:
C6 (rat glial tumor cell line) whole cell lysate at 20 µg
Lane 2:
MCF7 (human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 3:
Mouse kidney lysate at 20 µg
Lane 4:
Rat kidney lysate at 20 µg
Lane 5:
Human kidney lysate at 20 µg
Lane 6:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 7:
SK-OV-3 (human ovarian cancer cell line) whole cell lysate at 20 µg
Secondary
Lanes 1, 2, 3, 4, 6 and 7:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lane 5:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
Related conjugates and formulations (1)
-
Anti-CPT1A antibody [EPR21843-71-2F] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.
What is the molecular weight of CPT1A?
Anti-CPT1A [EPR21843-71-2F] (ab234111) specifically detects a band for CPT1A (UniProt: P50416) at a molecular weight of 88kDa.
Trusted by the scientific community
Anti-CPT1A [EPR21843-71-2F] (ab234111) was first used in a scientific publication in 2018 and has been cited over 30 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) has been confirmed by Western blot testing in CPT1A Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR21843-71-2F] also available for your convenience: ab234111, Carrier free - ab235841
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CPT1A plays a vital role in energy production by facilitating mitochondrial fatty acid oxidation. It does not function as a solitary enzyme but often associates with other enzymes forming a multiprotein complex that includes acyl-CoA synthetase. This complex enables efficient fatty acid transport and oxidation converting stored fats into usable energy. As CPT1A primarily operates in the liver its activity significantly impacts overall lipid and energy homeostasis demonstrating its critical regulatory role.
Pathways
CPT1A is central to the fatty acid beta-oxidation pathway an important process for breaking down fatty acids to produce energy. This pathway also involves proteins such as CPT1B a related isoform present in muscle tissues. CPT1A's function is important in the liver's capacity to regulate energy balance and respond to metabolic demands. Additionally CPT1A interacts within the signaling pathway of AMPK (AMP-activated protein kinase) which further integrates it into broader metabolic regulation networks linking energy status to cellular function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (64)
Recent publications for all applications. Explore the full list and refine your search
BMC complementary medicine and therapies 25:365 PubMed41068844
2025
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 20:e0328139 PubMed40825027
2025
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 15:6516-6533 PubMed40521210
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:308 PubMed40240362
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 15:1143-1158 PubMed40177554
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1542143 PubMed40144651
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 15:256-277 PubMed40041918
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 24:34 PubMed39876004
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 22:302 PubMed39736678
2024
Applications
Unspecified application
Species
Unspecified reactive species
PPAR research 2024:4164906 PubMed39735727
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com